Five Star Equities Provides Stock Research on Array Biopharma and PDL BioPharma
Continue ReadingTag: stock-market
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on Acura Pharmaceuticals and Sunesis Pharmaceuticals
Continue Reading
U.S. Oil Refiners Slump on Concerns of Lower Margins Due to Rising Renewable Fuel Credits
RDInvesting Provides Stock Research on HollyFrontier and Valero Energy
Continue Reading
Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation
Five Star Equities Provides Stock Research on Cell Therapeutics and Santarus
Continue Reading
Retail Industry Showing Strength in 2013 as Commerce Department Reports 1.1% Increase in February Sales
Five Star Equities Provides Stock Research on American Eagle Outfitters and Urban Outfitters
Continue Reading
Smartphones Forecasted to Outsell Feature Phones for the First Time Ever in 2013
RDInvesting Provides Stock Research on Glu Mobile and Velti
Continue Reading
Long-Term Demand for Uranium to Be Driven by Emerging Nation — Miners Could Receive Boost From End of Russia-s Disarmament Treaty
Five Star Equities Provides Stock Research on Cameco and Denison Mines
Continue Reading
FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
Five Star Equities Provides Stock Research on AEterna Zentaris and Amicus Therapeutics
Continue Reading
Smartphone Demand Continues to Drive Growth Within Technology Sector — Smartphones Expected to Outsell Feature Phones in 2013
RDInvesting Provides Stock Research on Millennial Media and Vringo
Continue Reading
Smartphones Forecasted to Equate for Two-Thirds of Total Mobile Shipments by 2017
RDInvesting Provides Stock Research on InterDigital and VirnetX
Continue Reading